Healthcare Value Capital as of Sept. 30, 2013
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 42 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 8.0 | $9.1M | 192k | 47.61 | |
| Supernus Pharmaceuticals (SUPN) | 7.5 | $8.5M | 1.2M | 7.33 | |
| iShares Russell 2000 Index (IWM) | 7.0 | $8.0M | 75k | 106.61 | |
| Auxilium Pharmaceuticals | 6.1 | $7.0M | 385k | 18.20 | |
| Endo Pharmaceuticals | 6.0 | $6.8M | 150k | 45.44 | |
| Teva Pharmaceutical Industries (TEVA) | 5.0 | $5.7M | 150k | 37.78 | |
| SPDR S&P MidCap 400 ETF (MDY) | 5.0 | $5.7M | 25k | 226.32 | |
| Biosante Pharmaceuticals (ANIP) | 4.7 | $5.4M | 554k | 9.77 | |
| Eli Lilly & Co. (LLY) | 4.4 | $5.0M | 100k | 50.34 | |
| Health Net | 4.2 | $4.8M | 150k | 31.70 | |
| AstraZeneca (AZN) | 3.7 | $4.3M | 82k | 51.93 | |
| Spdr S&p 500 Etf (SPY) | 3.7 | $4.2M | 25k | 168.00 | |
| Quest Diagnostics Incorporated (DGX) | 3.6 | $4.2M | 67k | 61.79 | |
| Forest Laboratories | 2.6 | $3.0M | 70k | 42.80 | |
| GlaxoSmithKline | 2.0 | $2.3M | 46k | 50.17 | |
| Given Imaging | 1.9 | $2.1M | 110k | 19.23 | |
| Qlt | 1.7 | $2.0M | 432k | 4.61 | |
| Impax Laboratories | 1.7 | $2.0M | 97k | 20.47 | |
| ViroPharma Incorporated | 1.7 | $2.0M | 50k | 39.26 | |
| Cornerstone Therapeutics | 1.6 | $1.9M | 200k | 9.41 | |
| Humana (HUM) | 1.6 | $1.9M | 20k | 93.35 | |
| Solta Medical | 1.6 | $1.8M | 892k | 2.07 | |
| Actavis | 1.6 | $1.8M | 13k | 143.96 | |
| Sanofi-Aventis SA (SNY) | 1.4 | $1.7M | 33k | 50.62 | |
| Sagent Pharmaceuticals | 1.3 | $1.5M | 74k | 20.40 | |
| Vivus | 1.2 | $1.4M | 150k | 9.30 | |
| WellPoint | 1.1 | $1.3M | 15k | 83.60 | |
| CryoLife (AORT) | 1.0 | $1.1M | 158k | 6.99 | |
| Targacept | 0.9 | $1.1M | 203k | 5.31 | |
| Pacira Pharmaceuticals (PCRX) | 0.9 | $986k | 21k | 48.10 | |
| Medicines Company | 0.7 | $838k | 25k | 33.52 | |
| Biota Pharmaceuticals | 0.7 | $758k | 181k | 4.18 | |
| D Stemline Therapeutics | 0.7 | $746k | 17k | 45.31 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $566k | 50k | 11.32 | |
| Zogenix | 0.5 | $511k | 276k | 1.85 | |
| Cytokinetics (CYTK) | 0.4 | $429k | 57k | 7.57 | |
| Sunesis Pharmaceuticals | 0.4 | $413k | 83k | 4.96 | |
| Anacor Pharmaceuticals In | 0.3 | $401k | 38k | 10.63 | |
| ZIOPHARM Oncology | 0.3 | $394k | 100k | 3.94 | |
| Amicus Therapeutics (FOLD) | 0.3 | $313k | 135k | 2.32 | |
| Achillion Pharmaceuticals | 0.3 | $302k | 100k | 3.02 | |
| XenoPort | 0.2 | $284k | 50k | 5.68 |
